AU StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

AROA BIOSURGERY LTD

0.710

+0.0304.41%

Volume:114.64K

Turnover:80.19K

Market Cap:244.97M

PE:-157.01

High:0.710

Open:0.690

Low:0.685

Close:0.680

52wk High:0.800

52wk Low:0.350

Shares:345.03M

Float Shares:258.64M

Volume Ratio:0.54

T/O Rate:0.04%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.005

EPS(LYR):-0.009

ROE:-1.97%

ROA:0.37%

PB:3.11

PE(LYR):-75.37

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks

Simply Wall St.

BUZZ-Aroa Biosurgery eyes annual results at top end of forecast, shares rise

Aroa Biosurgery Reaffirms Fiscal 2026 Revenue, Normalized EBITDA Guidance

MT Newswires Live

Aroa Biosurgery Ltd - Expects FY26 Revenue at Upper End of Nz$92-100 Mln

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARX.AU"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARX.AU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","market":"AU","secType":"STK","nameCN":"AROA BIOSURGERY LTD","latestPrice":0.71,"timestamp":1770786720000,"preClose":0.68,"halted":0,"volume":114638,"delay":0,"changeRate":0.0441176470588234,"nameEN":"AROA BIOSURGERY LTD","floatShares":258636705,"shares":345033235,"eps":-0.004524273754691412,"marketStatus":"Closed","change":0.03,"latestTime":"02-11 16:12:00 AEDT","open":0.69,"high":0.71,"low":0.685,"amount":80188,"amplitude":0.036765,"askPrice":0.71,"askSize":13827,"bidPrice":0.685,"bidSize":9804,"shortable":3,"etf":0,"ttmEps":-0.004524273754691412,"tradingStatus":0,"nextMarketStatus":{"tag":"Open","tradingStatus":0,"beginTime":1770850800000},"marketStatusCode":5,"adr":0,"exchange":"ASX","adjPreClose":0.68,"openAndCloseTimeList":[[1770764400000,1770786000000]],"volumeRatio":0.53809,"lotSize":1,"tradeCurrency":"AUD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:true,,method:\"POST\",data:#items:@#symbol:\"ARX.AU\",,,,,undefined,":{"symbol":"ARX.AU","floatShares":258636705,"roa":"0.37%","roe":"-1.97%","lyrEps":-0.00942,"volumeRatio":0.53809,"shares":345033235,"dividePrice":0,"high":0.71,"amplitude":0.036765,"preClose":0.68,"low":0.685,"week52Low":0.35,"pbRate":"3.11","psRate":"3.18","week52High":0.8,"institutionHeld":0,"latestPrice":0.71,"committee":-0.170242,"eps":-0.004521965570852709,"divideRate":0,"volume":114638,"delay":0,"ttmEps":-0.004521965570852709,"open":0.69,"prevYearClose":0.74,"prevWeekClose":0.65,"prevMonthClose":0.625,"prevQuarterClose":0.74,"fiveDayClose":0.68,"twentyDayClose":0.76,"sixtyDayClose":0.765},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARX.AU\",params:#limit:5,,,undefined,":[{"date":"2025-11-24","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1763938800000,"name":null,"time":"","dateTimestamp":1763902800000,"actualEps":null},{"date":"2025-10-30","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1761778800000,"name":null,"time":"","dateTimestamp":1761742800000,"actualEps":null},{"date":"2025-10-15","symbol":"ARX.AU","type":"earning","reportTimeType":"pre","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1760482800000,"name":null,"time":"Pre-Market","dateTimestamp":1760446800000,"actualEps":null},{"date":"2025-07-28","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1753660800000,"name":null,"time":"","dateTimestamp":1753624800000,"actualEps":null},{"date":"2025-06-30","symbol":"ARX.AU","type":"earning","reportTimeType":"","market":"AU","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1751241600000,"name":null,"time":"","dateTimestamp":1751205600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARX.AU\",market:\"AU\",,,undefined,":[],"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARX.AU\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2610505033","title":"ASX Opportunities: Aroa Biosurgery And 2 Other Promising Penny Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=2610505033","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610505033?lang=en_us&edition=fundamental","pubTime":"2026-02-09 03:02","pubTimestamp":1770577340,"startTime":"0","endTime":"0","summary":"The Australian market is experiencing a challenging period, with a significant downturn influenced by global market pressures and recent tech selloffs. Despite the turbulence, investors often seek opportunities in penny stocks, which can offer unique value propositions when backed by strong financials. These smaller or newer companies may present potential for growth and stability, making them intriguing options for those looking to uncover hidden gems in the stock market.","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cyp/cynata-therapeutics-shares/news/asx-opportunities-aroa-biosurgery-and-2-other-promising-penn","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-cyp/cynata-therapeutics-shares/news/asx-opportunities-aroa-biosurgery-and-2-other-promising-penn","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BVR.AU","MTO.AU","BK7077","BK7055","IGL.AU","ARX.AU","BK7128","BK7050","WAF.AU","BK7104","BK7508","BK7501","BK7503","BK7062","BK7016","BK7095","BK7506","AAL.AU","MXI.AU","VRS.AU","SSM.AU","PPS.AU","DSK.AU","AEF.AU","BK7067","BK7143","CYP.AU","BK7045"],"gpt_icon":0},{"id":"2608145118","title":"BUZZ-Aroa Biosurgery eyes annual results at top end of forecast, shares rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2608145118","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608145118?lang=en_us&edition=fundamental","pubTime":"2026-02-03 08:59","pubTimestamp":1770080398,"startTime":"0","endTime":"0","summary":"BUZZ-Aroa Biosurgery eyes annual results at top end of forecast, shares rise** Shares of soft-tissue regeneration products maker Aroa Biosurgery ARX.AX rise as much as 12.5% to A$0.72, their highest level since January 27** The New Zealand-based co expects its FY26 results to fall at the upper end of the revenue forecast range of NZ$92 million to NZ$100 million  and normalised EBITDA of NZ$5 million to NZ$8 million ** About 148,390 shares change hands, 1.5x the 30-day average ** YTD, stock down 2.7% this year, including the day's move","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260203:nL4N3YZ02G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARX.AU","BK7067"],"gpt_icon":0},{"id":"2608508816","title":"Aroa Biosurgery Reaffirms Fiscal 2026 Revenue, Normalized EBITDA Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2608508816","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608508816?lang=en_us&edition=fundamental","pubTime":"2026-02-03 07:18","pubTimestamp":1770074318,"startTime":"0","endTime":"0","summary":"Aroa Biosurgery  said that it expects its fiscal 2026 revenue to be at the upper end of the guidance range of NZ$92 million to NZ$100 million, according to a Tuesday filing with the Australian bourse.The company also said that it expects its normalized earnings before interest, taxes, depreciation, and amortization for the fiscal year to be at the upper end of the guidance range of NZ$5 million to NZ$8 million.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARX.AU","BK7067"],"gpt_icon":0},{"id":"2608081879","title":"Aroa Biosurgery Ltd - Expects FY26 Revenue at Upper End of Nz$92-100 Mln","url":"https://stock-news.laohu8.com/highlight/detail?id=2608081879","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608081879?lang=en_us&edition=fundamental","pubTime":"2026-02-03 05:46","pubTimestamp":1770068765,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nFWN3YY1DE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK7067","ARX.AU"],"gpt_icon":0}],"pageSize":4,"totalPage":8,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/ARX.AU\",params:#limit:6,delay:true,,,undefined,":[]}}